MEDTRONIC HEART VALVES DIVISION EVOLUT FX DCS; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIV
|
Back to Search Results |
|
Model Number D-EVOLUTFX-34 |
Device Problems
Material Invagination (1336); Device Dislodged or Dislocated (2923)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 04/01/2024 |
Event Type
malfunction
|
Event Description
|
Medtronic received information that prior to the attempted implant of this transcatheter bioprosthetic valve in a patient with calcified anatomy, a pre-implant balloon aortic valvuloplasty (bav) was performed.Following the bav, the deployment was attempted at 80%; however, the valve dislodged, and was recaptured into the delivery catheter system (dcs).On the second deployment attempt at a depth of 3mm, an infold in the valve frame was observed.The valve was recaptured into the dcs, and the system was withdrawn from the patient.Subsequently, a new valve was loaded into a new dcs and successfully implanted in the patient.This resulted in a 10-minute procedural delay.No adverse patient effects were reported.
|
|
Manufacturer Narrative
|
Continuation of d10: section d information references the main component of the system.Other relevant device(s) are: product id: e volutfx-34, serial/lot #: (b)(6), ubd: 27-jan-2026, udi#: (b)(4).Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Manufacturer Narrative
|
Updated data: a3b b5 continuation of d10: product id (b)(4); product lot/serial number ; product type: guidewire.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Event Description
|
Additional information was received that during the valve implant, prior to the valve dislodgement, the implant depth was 3 millimeter (mm) on the non-coronary cusp (ncc) and 3 mm on the left coronary cusp (lcc).After the valve dislodged, the implant depth was 15 mm on the ncc and 15 mm on the lcc.The direction of the valve dislodgement was aortic.A non-medtronic guidewire (safari) was used during the implant.
|
|
Search Alerts/Recalls
|
|
|